PDSB

PDS Biotechnology Corporation Common Stock (PDSB)

Stock · NASDAQ · Health Care

$0.211as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$0.663188
Industry
Biotechnology: Pharmaceutical Preparations

PDS Biotechnology Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • PDSB
    PDS Biotechnology Corporation Common Stock
    $0.211
    ▼ 3.21%
    Market cap $39.95MP/E
  • HYPD
    Hyperion DeFi Inc. Common Stock
    $3.25
    ▼ 10.36%
    Market cap $40.32MP/E
    $2.34$15
  • NNVC
    NanoViricides Inc. Common Stock
    $1.24
    ▼ 3.12%
    Market cap $39.37MP/E
    $0.85$2.23
  • APLM
    Apollomics Inc. Class A Ordinary Shares
    $26.6
    ▲ 1.14%
    Market cap $37.33MP/E
    $3.66$42.12
  • ENLV
    Enlivex Ltd. Ordinary Shares
    $1.35
    ▼ 8.47%
    Market cap $36.53MP/E 0.02
    $1.35$27.15
  • KPTI
    Karyopharm Therapeutics Inc. Common Stock
    $1.88
    ▼ 3.09%
    Market cap $44.65MP/E
    $1.79$10.99
  • RADX
    Radiopharm Theranostics Limited American Depositary Shares
    $2.41
    ▲ 6.64%
    Market cap $44.71MP/E
    $0.009$0.04

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
5.06M
Total value held
$3.05M
Institutional holders
39
Top holders this quarter
  • Unknown1.63M
  • Unknown660.2K
  • Unknown554.0K
  • Unknown319.1K
  • Unknown300.0K
  • Unknown220.8K
  • Unknown182.0K
  • Unknown173.6K
  • Unknown133.3K
  • Unknown110.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.